Kedrion SpA   Report issue

For profit Phase 1 Phase 3
Founded: Fort Lee NJ United States (2011)
Status: No NME R&D (2011)

Organization Overview

First Clinical Trial
2012
NCT01554956
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Humán Bioplazma Kft - Kedrion | Kedrion SpA | Kedrion S.p.A.